Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI.
about
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancerBeyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaLate toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children.Patterns of patient specific dosimetry in total body irradiation.Psychometric properties of the Oral Mucositis Daily Questionnaire for child self-report and importance of mucositis in children treated with chemotherapy.Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer
P2860
Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Early outcomes after allogenei ...... following single fraction TBI.
@en
Early outcomes after allogenei ...... following single fraction TBI.
@nl
type
label
Early outcomes after allogenei ...... following single fraction TBI.
@en
Early outcomes after allogenei ...... following single fraction TBI.
@nl
prefLabel
Early outcomes after allogenei ...... following single fraction TBI.
@en
Early outcomes after allogenei ...... following single fraction TBI.
@nl
P2093
P2860
P356
P1476
Early outcomes after allogenei ...... following single fraction TBI.
@en
P2093
D B Mansur
J F DiPersio
K Trinkaus
Q Jean Zhang
T E Druley
P2860
P2888
P304
P356
10.1038/BMT.2008.327
P407
P577
2008-11-17T00:00:00Z
P5875
P6179
1022296273